Erector Spinae Plane Block vs Transforaminal Epidural Injection

Erector Spinae Plane Block Versus Transforaminal Epidural Injection in Chronic Discogenic Low Back Pain

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04212845

Enrollment

Registered

2019-12-30

Start date

2020-01-02

Completion date

2020-09-01

Last updated

2020-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discogenic Low Back Pain

Brief summary

Lumbar disc herniation is the main cause of low back pain and radicular leg pain. Steroids administered to the epidural area reduce the inflammatory response and pain by inhibiting the synthesis of proinflammatory agents. Epidural steroid injections are used in the treatment of lumbosacral radicular pain with various techniques including fluoroscopy-guided transforaminal and interlaminar injection. Ultrasound-guided erector spina plan block (ESPB) was first described in 2016 and has been used for postoperative analgesia in many surgeries including thoracic and lumbar dermatomes. The distribution of local anesthesia in the ESPB from the paravertebral area to the transforaminal and epidural space has been shown in studies. The aim of this study was to compare the efficacy of ultrasound-guided ESPB and fluoroscopic guided transforaminal epidural steroid injection in chronic discogenic low back pain.

Interventions

DRUGBupivacaine;Dexamethasone Solution for Injection

8 mg Dexamethasone and %0.25 bupivacaine

DEVICEFluoroscopy

Fluoroscopy-guided transforaminal injection

DEVICEUltrasound

Ultrasound-guided erector spinae plane block

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* American Society of Anesthesiologist's physiologic state I-III patients * Patients with unilateral radicular pain and low back pain persisting despite medical treatment.

Exclusion criteria

* Spinal cord disease or spinal mechanical instability, * Previous low back surgery, * More than two levels of lumbar disc hernia, * Allergic to local anesthetic drugs to be used, * Use of oral anticoagulants, * Uncontrolled diabetes mellitus type I and II

Design outcomes

Primary

Measure	Time frame	Description
Visual analog pain score	Post injection sixth month	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Secondary

Measure	Time frame	Description
Oswestry Disability Index	Post injection first, third and sixth month	0% -20%: Minimal disability, 21%-40%: Moderate Disability, 41%-60%: Severe Disability, 61%-80%: Crippling back pain, 81%-100%: These patients are either bed-bound or have an exaggeration of their symptoms.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAhmet Yayik, MD

m_yayik@hotmail.com00905544259287

Backup ContactAli Ahiskalioglu, MD

aliahiskalioglu@hotmail.com00905444424831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026